Lenard A. Adler, MD

Viloxazine ER in Adults With ADHD and Depression and/or Anxiety Symptoms

May 27, 2026

Viloxazine ER was well tolerated and associated with improvements in ADHD, depression, and anxiety symptoms in this real-world study.

Lenard A. Adler, V. Rose Lieberman, Leslie Brijbasi, et al

Original Research

Lisdexamfetamine for Sluggish Cognitive Tempo and Adult ADHD

June 29, 2021

Many patients with ADHD have “sluggish cognitive tempo,” characterized by daydreaming, being underactive, and feeling spacey and lethargic. This RCT evaluated the use of lisdexamfetamine in adults to reduce...

Lenard A. Adler, Terry L. Leon, Taylor M. Sardoff, et al

Original Research

Lisdexamfetamine Dimesylate in Adults With Attention-Deficit/ Hyperactivity Disorder Who Report Clinically Significant Impairment in Executive Function: Results From a Randomized, Double-Blind, Placebo-Controlled Study

July 15, 2013

Lenard A. Adler, Bryan Dirks, Richard H. Weisler, et al

Original Research

A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study Evaluating the Efficacy, Safety, and Tolerability of Extended-Release Metadoxine in Adults With Attention-Deficit/Hyperactivity Disorder

December 15, 2012

Lenard A. Adler, Joseph Biederman, Jeffrey H. Newcorn, et al

Original Research

Randomized Controlled Study of the Histamine H3 Inverse Agonist MK-0249 in Adult Attention-Deficit/Hyperactivity Disorder

July 15, 2012

David Michelson, Lenard A. Adler, Timothy E. Wilens, et al

Original Research

An 8-Week, Randomized Controlled Trial of Atomoxetine, Atomoxetine Plus Buspirone, or Placebo in Adults With ADHD

January 10, 2012

Lenard A. Adler, Suzanne M. Sutherland, Crystal Chen, et al

Educational Activity

Administering and Evaluating the Results of the Adult ADHD Self-Report Scale (ASRS) in Adolescents

June 15, 2011

Lenard A. Adler, Jeffrey H. Newcorn

Educational Activity

Assessing Adolescents Using ADHD Rating Scales

May 15, 2011

Lenard A. Adler, Jeffrey H. Newcorn

Educational Activity

Performance Improvement CME: Adult ADHD

April 15, 2011

Russell A. Barkley, Lenard A. Adler, Jeffrey H. Newcorn

Educational Activity

Monitoring Adults With ADHD: A Focus on Executive and Behavioral Function

August 15, 2010

Lenard A. Adler

Original Research

Impact of Attention-Deficit/Hyperactivity Disorder (ADHD) Treatment on Smoking Cessation Intervention in ADHD Smokers: A Randomized, Double-Blind, Placebo-Controlled Trial

May 18, 2010

Lenard A. Adler, Roger D. Weiss, Theresa M. Winhusen, et al

Original Research

Short-Term Effects of Lisdexamfetamine Dimesylate on Cardiovascular Parameters in a 4-Week Clinical Trial in Adults With Attention-Deficit/Hyperactivity Disorder

December 15, 2009

Lenard A. Adler, Richard H. Weisler, David W. Goodman, et al

Viloxazine ER in Adults With ADHD and Depression and/or Anxiety Symptoms

Lisdexamfetamine for Sluggish Cognitive Tempo and Adult ADHD

Lisdexamfetamine Dimesylate in Adults With Attention-Deficit/ Hyperactivity Disorder Who Report Clinically Significant Impairment in Executive Function: Results From a Randomized, Double-Blind, Placebo-Controlled Study

A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study Evaluating the Efficacy, Safety, and Tolerability of Extended-Release Metadoxine in Adults With Attention-Deficit/Hyperactivity Disorder

Randomized Controlled Study of the Histamine H3 Inverse Agonist MK-0249 in Adult Attention-Deficit/Hyperactivity Disorder

An 8-Week, Randomized Controlled Trial of Atomoxetine, Atomoxetine Plus Buspirone, or Placebo in Adults With ADHD

Administering and Evaluating the Results of the Adult ADHD Self-Report Scale (ASRS) in Adolescents

Assessing Adolescents Using ADHD Rating Scales

Performance Improvement CME: Adult ADHD

Monitoring Adults With ADHD: A Focus on Executive and Behavioral Function

Impact of Attention-Deficit/Hyperactivity Disorder (ADHD) Treatment on Smoking Cessation Intervention in ADHD Smokers: A Randomized, Double-Blind, Placebo-Controlled Trial

Short-Term Effects of Lisdexamfetamine Dimesylate on Cardiovascular Parameters in a 4-Week Clinical Trial in Adults With Attention-Deficit/Hyperactivity Disorder

ELSEWHERE:

FOLLOW US:

Lenard A. Adler, MD

Viloxazine ER in Adults With ADHD and Depression and/or Anxiety Symptoms

Lisdexamfetamine for Sluggish Cognitive Tempo and Adult ADHD

Lisdexamfetamine Dimesylate in Adults With Attention-Deficit/ Hyperactivity Disorder Who Report Clinically Significant Impairment in Executive Function: Results From a Randomized, Double-Blind, Placebo-Controlled Study

A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study Evaluating the Efficacy, Safety, and Tolerability of Extended-Release Metadoxine in Adults With Attention-Deficit/Hyperactivity Disorder

Randomized Controlled Study of the Histamine H3 Inverse Agonist MK-0249 in Adult Attention-Deficit/Hyperactivity Disorder

An 8-Week, Randomized Controlled Trial of Atomoxetine, Atomoxetine Plus Buspirone, or Placebo in Adults With ADHD

Administering and Evaluating the Results of the Adult ADHD Self-Report Scale (ASRS) in Adolescents

Assessing Adolescents Using ADHD Rating Scales

Performance Improvement CME: Adult ADHD

Monitoring Adults With ADHD: A Focus on Executive and Behavioral Function

Impact of Attention-Deficit/Hyperactivity Disorder (ADHD) Treatment on Smoking Cessation Intervention in ADHD Smokers: A Randomized, Double-Blind, Placebo-Controlled Trial

Short-Term Effects of Lisdexamfetamine Dimesylate on Cardiovascular Parameters in a 4-Week Clinical Trial in Adults With Attention-Deficit/Hyperactivity Disorder

Insightful. Evidence-based. Human-centered.

Subscribe to readmore articles

Subscribe to read
more articles